With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval

With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval

Submitted by admin on November 2, 2018 - 7:54pm
Source: 
Xconomy
News Tags: 
FDA
advisory panels
SAGE Therapeutics
postpartum depression
brexanolone
Headline: 
With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval
snippet: 

A panel of experts on Friday voted in favor of bringing what could be the first-ever drug approved specifically for postpartum depression to market. 

Do Not Allow Advertisers to Use My Personal information